Analysis on status quo and related factors of delays in diagnosis and treatment of breast cancer in Ningxia Hui Autonomous Region
- PMID: 38669416
- PMCID: PMC11049709
- DOI: 10.1097/MD.0000000000037826
Analysis on status quo and related factors of delays in diagnosis and treatment of breast cancer in Ningxia Hui Autonomous Region
Abstract
This study aimed to explore factors contributing to the delays in the diagnosis and treatment of breast cancer (BC) in Ningxia Hui Autonomous Region. We conducted a cohort analysis of 1012 patients with BC diagnosed at the General Hospital of Ningxia Medical University between January 2018 and December 2019. Sociodemographic data were collected through questionnaires, and clinical data were gathered and analyzed from relevant databases. Furthermore, observations were made regarding delays in the diagnosis and treatment of BC, followed by an analysis of the correlations between patient delay and both sociological factors within the population and clinical factors specific to patients with BC. Subsequently, the factors associated with patient delay and system delay were examined using Cox regression analysis, along with the inclusion of neoadjuvant therapy. In the prevention and treatment of BC in Ningxia, the patient delay rate was 33.20%, the diagnosis delay rate was 17.89%, the treatment delay rate was 0.0099% and the system delay rate was 41.60%. There was a higher proportion of patient delay and system delay in aged patients (age ≥ 61 years) with rural registered permanent residence (RPR), multiple clinical symptoms (such as nipple spillage, axillary abnormalities, etc), a T4 tumor size classification, and the initial use of neoadjuvant therapy. Besides, significant positive correlations were observed between patient delay and system delay time with BC stage. Patients aged 51 to 60 and those with molecular types (Limanal1B: ki-67 > 14%, Limanal1B: HER-2 positive) were prone to patient delay, whereas molecular characteristics influenced system delay, unrelated to sociodemographic factors. The study identifies significant age, residency, and tumor molecular subtype correlations with diagnostic and treatment delays in Ningxia's patients with BC, predominantly affecting women aged 41 to 60, especially urban dwellers. These findings underscore the need for targeted interventions to reduce delays and improve BC care in this region.
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Effect of Sociodemographic Variables on Patient and Diagnostic Delay of Breast Cancer at the Foremost Health Care Institution in Nigeria.J Glob Oncol. 2019 Jul;5:1-8. doi: 10.1200/JGO.19.00108. J Glob Oncol. 2019. PMID: 31348736 Free PMC article.
-
Delays in the presentation and diagnosis of women with breast cancer in Yogyakarta, Indonesia: A retrospective observational study.PLoS One. 2022 Jan 13;17(1):e0262468. doi: 10.1371/journal.pone.0262468. eCollection 2022. PLoS One. 2022. PMID: 35025941 Free PMC article.
-
Impact of COVID-19 Pandemic on Pre-Treatment Delays, Detection, and Clinical Characteristics of Tuberculosis Patients in Ningxia Hui Autonomous Region, China.Front Public Health. 2021 May 21;9:644536. doi: 10.3389/fpubh.2021.644536. eCollection 2021. Front Public Health. 2021. PMID: 34095053 Free PMC article.
-
Factors influencing the time to diagnosis and treatment of breast cancer among women in low- and middle-income countries: A systematic review.Breast. 2024 Jun;75:103714. doi: 10.1016/j.breast.2024.103714. Epub 2024 Mar 18. Breast. 2024. PMID: 38522173 Free PMC article. Review.
-
Delayed Presentation, Diagnosis, and Treatment of Breast Cancer Among Chinese Women: An Integrative Literature Review.Cancer Nurs. 2023 May-Jun 01;46(3):217-232. doi: 10.1097/NCC.0000000000001074. Epub 2022 Mar 11. Cancer Nurs. 2023. PMID: 35283469 Review.
References
-
- Loibl S, Poortmans P, Morrow M, et al. . Breast cancer. Lancet. 2021;397:1750–69. - PubMed
-
- Budny A, Staroslawska E, Budny B, et al. . [Epidemiology and diagnosis of breast cancer]. Pol Merkur Lekarski. 2019;46:195–204. - PubMed
-
- Sopik V. International variation in breast cancer incidence and mortality in young women. Breast Cancer Res Treat. 2021;186:497–507. - PubMed
-
- Wang J, Xiu BQ, Guo R, et al. . [Current trend of breast cancer neoadjuvant treatment in China: a cross-sectional study]. Zhonghua Zhong Liu Za Zhi. 2020;42:931–6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous